Suppliers results

"New Zealand Pharmaceuticals Ltd was established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry. The company's first products were pharmaceutical intermediates extracted from bovine or ovine bile. Over the next 15 years NZP's reputation for quality and service allowed it to become one of the major manufacturers and suppliers of these products to the market. The product range broadened to include a variety of other biochemicals from the meat industry. The acquisition of Dextra Laboratories in 2009 extended NZP's offering to the market. Dextra's primary area of expertise is the design and synthesis of complex carbohydrates and derivatives, with extensive know-how and patents in a number of areas; most notably its blood group antigen products."

"Welcome to CARBOGEN AMCIS, a member of the Dishman Carbogen Amcis Group. We provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. Our capabilities span from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) - as well as drug products for preclinical studies, clinical trials and commercial use. Besides being a service provider we also offer high quality Cholesterol and Vitamin D analog products produced at our facility in The Netherlands. These products are used in a variety of markets around the globe. Our focus is to help customers create a better world by becoming the partner of choice for development and manufacture. The guiding principles for our service are our passion for great science supported by timely communication and backed by our total commitment to YOUR project. We forge close collaboration and open communication with our customers which ensures we work effectively as a team, meeting (if not exceeding) our customers' expectations. We aim to manufacture pharmaceutical ingredients at the highest standard of GMP whilst protecting the environment. Our products and services contribute to a safe food and medicine supply. We differentiate through the deployment of experienced, creative, disciplined and motivated staff who have an absolute passion for communication, transparency and focus on every task we perform for the Dishman Carbogen Amcis Group, our partners, regulators and, of course, our customers."

DPL-US, a member of the Dr. Paul Lohmann family of companies, is a US based company serving the US market providing high value mineral salts since 2005. Our parent company, Dr. Paul Lohmann GmbH KG, has been producing mineral salts since 1886 and produces over 350 different mineral salts at our two ISO and GMP certified production sites in Germany.

Vantage is an industrial scale pharmaceutical CMO and extraction company based in Greeley, CO, producing CO2 and hydrocarbon extracted API quality CBD ingredients and finished goods, which are then sold globally. Our facilities are ICH Q7 and WHO GMP certified by SGS for the production of API's and finished products

MB Med. Is a company with a commercial vocation that was born in January 2006 from the reorganization of the D. Ulrich Company, which had already become Martin Bauer SpA, to meet the needs of the nutraceutical market and with the aim of being a supplier specialized in extracts. and vegetable powders for the nutraceutical and food industry.

"We, Aoxing Biotechnology Intl Co., Limited, have 3 production bases, Aoxing Biotechnology Co., Ltd., Ningbo Zhenhai Amino-Acids Factory and Hebei Jihai Biology Technology Co., Ltd., respectively located in Zhejiang Province and Hebei Province in China. Aoxing Biotechnology Co., Ltd. is a new-type pharmaceutical bio-tech company which was designed with the total investment of 8 million US dollars, total area of 63000 square meters. We are specialized in manufacturing two large product categories Chitosan series, Glucosamine series and Chondroitine Sulfate. As the earliest ISO9001 quality system, HACCP and FDA approved company in this trade of China, we have 1,000sqm of GMP-standard (100,000 grade of cleanliness) plant, and modern pharmaceutical and granulating production equipment. As the only qualified manufacturer of APIs, we are the first enterprise in China that performance our production according to the standards of USP with the annual capacity for 1000 tons D-Glucosamine Hydrochloride, 300 tons N-Acetyl-D-Glucosamine and 200 tons chitosan with different molecular weight and viscosity together with 100 tons high density grade chitosan (national patent). Now, the qualities and inspection methods of our products can meet USP standards completely. Moreover, we are the first E-DMF licensed company in Glucosamine industry of China, its production is under the GMP standard too. Modern GMP manufacturing workshop, advanced analysis equipment, high-tech products with proprietary intellectual property rights and many patents for new high-tech products have well shown a powerful company with economic strength and technology force. Established in 1990, Ningbo Zhenhai Amino-Acids Factory located by the beautiful East China Sea and is easily accessible from other cities by bus, railroad, ship or plane. The factory occupies an area of 10,000 square meters with fixed capital of 10 million RMB. We use advanced technology and latest in manufacturing equipment, and has the annual capacity of Amino Acid for 2000 tons."

Together with our customers, Roquette addresses societal challenges by unlocking the potential of nature to offer the best ingredients for food, nutrition and health markets. These ingredients respond to unique and essential needs, enable healthier lifestyles and are critical components of life-saving medicines. We're improving the well-being of millions of people all over the world while taking care of resources and territories.

"Nanjing Biotogether Co.,Ltd. is a leading sicence-based company in China, active in R&D, manufacture and sales of high-tech products. Biotogether is one branch subordinate to the National Engineering Research for Biotechnology (NERCB), China, a High-tech Enterprise of Nanjing. The leading products are Nucleotides, Fructose-1,6-Diphosphate, α-Amylase Inhibitor. It involves intermediates, food additives, feed additives, and raw materials for cosmetics and nutrition etc. Since its establishment in 2005, it has been adhered to the developmental concept of “developing the biotechnology with good prospects, promoting the health and well-being of all mankind”, has depended on the key technologies from NERCB and cooperated with Pingkai Ouyang who is a member of Chinese Academy of Engineering (CAE) and a group of experts. We have achieved great innovation in key technologies, including the source of biocatalyst, biocatalysis process, the separation mediums and methods and the crystal system. We have acquired 8 granted patents and 25 filed patents. The company has adopted many domestic and international certifications, including the ISO-9000 quality management system, “HACCP”, “HALAL” and “KOSHER”. At present, our products have gradually dominated the domestic market and entered international market of Europe and America."

Founded in 1935, Alchem International Pvt. Ltd. is a pioneer in the field of Phytochemicals with over 75 years of experience in providing plant derived active ingredients to the Pharmaceutical, Cosmetic and Nutraceutical industries across 35 countries globally. We have over 1000 employees worldwide, with 3 manufacturing sites across India and 4 International divisions with offices in India, Europe, Hong Kong and the United States. Alchem International Pvt. Ltd. is an export orientated company with sales in over 35 countries. 90% of the production is exported out of India. We have filed regulatory dossiers in over 20 countries. Domestically, our Alchem Phytoceuticals and EpiQue divisions are dynamic, innovative and fast growing providers of healthcare and cosmetic finished products to the Indian market with an eye on international expansion.